What is Cardinal Health Inc's earnings per share (EPS)?

Cardinal Health Inc (CAH) reported diluted earnings per share of $7.23 for fiscal year 2026. This represents a 12.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cardinal Health Inc Financials

CAH

FY2026 annual

Revenue $254.2B +14.2% YoY

Net Income $1.7B +9.8% YoY

EPS (Diluted) $7.23 +12.1% YoY

Free Cash Flow $4.5B +144.6% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Aug 11, 2026 Currency USD FYE June

Cardinal Health Inc (CAH) reported $254.2B in revenue for fiscal year 2026, up 14.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CAH FY2026 2026-08-15

High-volume distribution converts modest margins into cash while operating with structurally negative equity.

In FY2026, operating cash flow of $5.2B exceeded net income of $1.7B, showing earnings are not the main limit on cash generation. Free cash flow reached $4.5B after capital spending, even as the current ratio fell to 0.9x, linking strong cash output with tighter short-term coverage.

The business earns a 3.8% gross margin but only a 1.0% operating margin in FY2026, so overhead and operating costs consume most of the gross spread. That structure makes modest margin changes economically meaningful at this scale.

Negative equity persisted at -$2.9B in FY2026 while long-term debt was $7.0B, so conventional debt-to-equity readings are distorted and solvency must be read through liabilities, liquidity, and cash generation. Current liabilities of $43.9B exceeded current assets of $38.8B, indicating short-term obligations rely on continuous operating funding rather than a surplus of current assets.

Financial Health Signals

Financial Health Score 45/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cardinal Health Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cardinal Health Inc has an operating margin of 1.0%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is unchanged from the prior year.

Growth

Cardinal Health Inc's revenue grew 14.2% year-over-year to $254.2B, a solid pace of expansion. This earns a growth score of 54/100.

Leverage

Liquidity

Cardinal Health Inc's current ratio of 0.88 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Cardinal Health Inc has a free cash flow margin of 1.8%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Altman Z-Score Safe

5.07

Cardinal Health Inc scores 5.07, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Cardinal Health Inc passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

3.02x

For every $1 of reported earnings, Cardinal Health Inc generates $3.02 in operating cash flow ($5.2B OCF vs $1.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

7.51x

Cardinal Health Inc earns $7.51 in operating income for every $1 of interest expense ($2.6B vs $348.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$254.2B

YoY+14.2%

5Y CAGR+9.4%

10Y CAGR+7.7%

Cardinal Health Inc generated $254.2B in revenue in fiscal year 2026. This represents an increase of 14.2% from the prior year.

EBITDA

$3.6B

YoY+16.4%

5Y CAGR+23.2%

10Y CAGR+1.4%

Cardinal Health Inc's EBITDA was $3.6B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.4% from the prior year.

Net Income

$1.7B

YoY+9.8%

5Y CAGR+22.9%

10Y CAGR+1.8%

Cardinal Health Inc reported $1.7B in net income in fiscal year 2026. This represents an increase of 9.8% from the prior year.

EPS (Diluted)

$7.23

YoY+12.1%

5Y CAGR+28.3%

10Y CAGR+5.3%

Cardinal Health Inc earned $7.23 per diluted share (EPS) in fiscal year 2026. This represents an increase of 12.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$4.5B

YoY+144.6%

5Y CAGR+17.4%

10Y CAGR+6.1%

Cardinal Health Inc generated $4.5B in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 144.6% from the prior year.

Cash & Debt

$4.9B

YoY+25.3%

5Y CAGR+7.3%

10Y CAGR+7.5%

Cardinal Health Inc held $4.9B in cash against $7.0B in long-term debt as of fiscal year 2026.

Dividends Per Share

$2.04

YoY+1.0%

5Y CAGR+1.0%

10Y CAGR+2.8%

Cardinal Health Inc paid $2.04 per share in dividends in fiscal year 2026. This represents an increase of 1.0% from the prior year.

Shares Outstanding

233M

YoY-2.6%

5Y CAGR-4.3%

10Y CAGR-3.1%

Cardinal Health Inc had 233M shares outstanding in fiscal year 2026. This represents a decrease of 2.6% from the prior year.

Margins & Returns

Gross Margin

3.8%

YoY+0.2pp

5Y CAGR-0.3pp

10Y CAGR-1.5pp

Cardinal Health Inc's gross margin was 3.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin

1.0%

YoY0.0pp

5Y CAGR+0.7pp

10Y CAGR-1.0pp

Cardinal Health Inc's operating margin was 1.0% in fiscal year 2026, reflecting core business profitability. That is unchanged from the prior year.

Net Margin

0.7%

YoY0.0pp

5Y CAGR+0.3pp

10Y CAGR-0.5pp

Cardinal Health Inc's net profit margin was 0.7% in fiscal year 2026, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity

Not reported for fiscal year 2026.

Capital Allocation

Share Buybacks

$1.4B

YoY+77.5%

5Y CAGR+46.7%

10Y CAGR+7.6%

Cardinal Health Inc spent $1.4B on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 77.5% from the prior year.

Capital Expenditures

$649.0M

YoY+18.6%

5Y CAGR+10.2%

10Y CAGR+3.4%

Cardinal Health Inc invested $649.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 18.6% from the prior year.

R&D Spending

Not reported for fiscal year 2026.

CAH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CAH quarterly income statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	$254.2B+14.2%	$222.6B-1.9%	$226.8B+10.7%	$205.0B+13.0%	$181.3B+11.6%	$162.5B+6.2%	$152.9B+5.1%	$145.5B+6.4%	$136.8B+5.3%	$130.0B+6.9%	$121.5B+18.5%	$102.5B+12.6%	$91.1B-9.9%	$101.1B-6.0%	$107.6B
Cost of Revenue	$244.5B+14.0%	$214.4B-2.3%	$219.4B+10.8%	$198.1B+13.3%	$174.8B+12.3%	$155.7B+6.6%	$146.1B+5.3%	$138.7B+7.0%	$129.6B+5.0%	$123.4B+7.3%	$115.0B+18.8%	$96.8B+12.7%	$85.9B-10.7%	$96.2B-6.6%	$103.0B
Gross Profit	$9.8B+19.7%	$8.2B+10.2%	$7.4B+7.9%	$6.9B+6.0%	$6.5B-4.3%	$6.8B-1.3%	$6.9B+0.5%	$6.8B-4.8%	$7.2B+9.7%	$6.5B0.0%	$6.5B+14.5%	$5.7B+10.7%	$5.2B+4.9%	$4.9B+8.4%	$4.5B
SG&A Expenses	$6.1B+13.9%	$5.4B+7.6%	$5.0B+4.2%	$4.8B+6.4%	$4.5B-0.5%	$4.5B-0.9%	$4.6B+2.1%	$4.5B-2.5%	$4.6B+21.7%	$3.8B+3.5%	$3.6B+12.6%	$3.2B+7.0%	$3.0B+5.3%	$2.9B+7.4%	$2.7B
Operating Income	$2.6B+14.9%	$2.3B+83.0%	$1.2B+65.3%	$752.0M+223.9%	-$607.0M-228.6%	$472.0M+111.5%	-$4.1B-298.9%	$2.1B+1534.9%	$126.0M-94.1%	$2.1B-13.8%	$2.5B+13.8%	$2.2B+14.6%	$1.9B+89.3%	$996.0M-44.4%	$1.8B
Interest Expense	$348.0M+61.9%	$215.0M+321.6%	$51.0M-39.3%	$84.0M-42.9%	$147.0M-18.3%	$180.0M-24.4%	$238.0M-19.0%	$294.0M-10.6%	$329.0M+63.7%	$201.0M+12.9%	$178.0M+26.2%	$141.0M+6.0%	$133.0M+8.1%	$123.0M+29.5%	$95.0M
Income Tax	$469.0M-11.8%	$532.0M+52.9%	$348.0M+4.8%	$332.0M+117.0%	$153.0M+152.9%	-$289.0M-265.8%	-$79.0M-120.5%	$386.0M+179.3%	-$487.0M-177.3%	$630.0M-25.4%	$845.0M+11.9%	$755.0M+18.9%	$635.0M+14.8%	$553.0M-11.9%	$628.0M
Net Income	$1.7B+9.8%	$1.6B+83.2%	$852.0M+158.2%	$330.0M+135.2%	-$938.0M-253.5%	$611.0M+116.5%	-$3.7B-371.2%	$1.4B+432.4%	$256.0M-80.1%	$1.3B-9.7%	$1.4B+17.4%	$1.2B+4.2%	$1.2B+249.1%	$334.0M-68.8%	$1.1B
EPS (Diluted)	$7.23+12.1%	$6.45+87.0%	$3.45+173.8%	$1.26+137.4%	-$3.37-262.0%	$2.08+116.5%	-$12.61-378.4%	$4.53+459.3%	$0.81-79.9%	$4.03-6.7%	$4.32+19.3%	$3.62+7.1%	$3.38+248.5%	$0.97-68.3%	$3.06

Metric	Q4'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$60.9B-7.1%	$65.6B+2.5%	$64.0B	N/A	N/A	$55.3B+5.7%	$52.3B-12.7%	$59.9B
Cost of Revenue	$58.4B-7.6%	$63.2B+2.5%	$61.7B	N/A	N/A	$53.3B+5.9%	$50.4B-13.1%	$58.0B
Gross Profit	$2.5B+4.2%	$2.4B+3.4%	$2.3B	N/A	N/A	$1.9B+2.1%	$1.9B+1.1%	$1.9B
SG&A Expenses	$1.5B+2.5%	$1.5B+2.9%	$1.5B	N/A	N/A	$1.3B+2.3%	$1.3B0.0%	$1.3B
Operating Income	$509.0M-28.0%	$707.0M+5.8%	$668.0M	N/A	N/A	$549.0M-3.3%	$568.0M+41.6%	$401.0M
Interest Expense	$101.0M+14.8%	$88.0M+10.0%	$80.0M	N/A	$74.0M+111.4%	$35.0M+9.4%	$32.0M+255.6%	$9.0M
Income Tax	$12.0M-92.5%	$159.0M+10.4%	$144.0M	N/A	N/A	$110.0M-11.3%	$124.0M-21.5%	$158.0M
Net Income	$399.0M-14.6%	$467.0M+3.8%	$450.0M	N/A	N/A	$400.0M-3.8%	$416.0M+77.0%	$235.0M
EPS (Diluted)	$1.69-14.2%	$1.97+4.8%	$1.88	N/A	N/A	$1.65-2.9%	$1.70	N/A

Not reported in any period shown, so not listed: R&D Expenses.

CAH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CAH quarterly balance sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Total Assets	$57.3B+7.9%	$53.1B+17.7%	$45.1B+4.1%	$43.3B-1.2%	$43.9B-1.3%	$44.5B+9.0%	$40.8B-0.5%	$41.0B+2.5%	$40.0B-0.4%	$40.1B+17.6%	$34.1B+13.2%	$30.1B+15.8%	$26.0B+0.8%	$25.8B+6.4%	$24.3B
Current Assets	$38.8B+6.5%	$36.4B+4.3%	$34.9B+3.4%	$33.7B+2.4%	$32.9B+6.1%	$31.0B+19.7%	$25.9B+0.7%	$25.7B+4.9%	$24.6B-13.4%	$28.3B+29.1%	$22.0B+0.9%	$21.8B+21.3%	$17.9B+1.0%	$17.8B+1.5%	$17.5B
Cash & Equivalents	$4.9B+25.3%	$3.9B-24.5%	$5.1B+25.9%	$4.1B-13.6%	$4.7B+38.5%	$3.4B+23.0%	$2.8B+9.5%	$2.5B+43.6%	$1.8B-74.4%	$6.9B+192.0%	$2.4B-49.0%	$4.6B+61.1%	$2.9B+50.7%	$1.9B-16.4%	$2.3B
Inventory	$17.3B+2.8%	$16.8B+12.5%	$15.0B-7.2%	$16.1B+3.1%	$15.6B+7.1%	$14.6B+10.6%	$13.2B+2.9%	$12.8B+4.2%	$12.3B+8.9%	$11.3B+6.5%	$10.6B+15.2%	$9.2B+11.4%	$8.3B-1.3%	$8.4B+6.5%	$7.9B
Goodwill	$11.4B+18.1%	$9.7B+105.1%	$4.7B+2.4%	$4.6B-21.2%	$5.9B-26.7%	$8.0B-4.4%	$8.4B-0.3%	$8.4B+0.7%	$8.3B+15.2%	$7.2B+0.8%	$7.2B+41.4%	$5.1B+3.9%	$4.9B+6.0%	$4.6B+15.7%	$4.0B
Total Liabilities	$60.2B+7.7%	$55.9B+15.7%	$48.3B+4.4%	$46.3B+3.9%	$44.6B+4.5%	$42.7B+9.5%	$39.0B+12.5%	$34.6B+2.2%	$33.9B+1.8%	$33.3B+20.8%	$27.6B+15.4%	$23.9B+21.7%	$19.6B-1.1%	$19.8B+10.1%	$18.0B
Current Liabilities	$43.9B+12.9%	$38.9B+9.1%	$35.6B+5.6%	$33.7B+10.4%	$30.6B+10.6%	$27.6B+17.0%	$23.6B-2.0%	$24.1B+5.3%	$22.9B+7.9%	$21.2B+7.7%	$19.7B+14.3%	$17.2B+14.1%	$15.1B+3.6%	$14.6B+2.9%	$14.2B
Long-Term Debt	$7.0B-12.2%	$8.0B+71.3%	$4.7B+19.2%	$3.9B-17.4%	$4.7B-11.7%	$5.4B-20.7%	$6.8B-10.7%	$7.6B-5.4%	$8.0B-11.6%	$9.1B+83.1%	$5.0B-5.0%	$5.2B+64.3%	$3.2B-14.0%	$3.7B+52.4%	$2.4B
Total Equity	-$2.9B-3.7%	-$2.8B+13.4%	-$3.2B-8.6%	-$3.0B-317.2%	-$709.0M-139.6%	$1.8B+0.1%	$1.8B-71.7%	$6.3B+4.4%	$6.1B-11.0%	$6.8B+3.9%	$6.6B+4.8%	$6.3B-2.3%	$6.4B+7.1%	$6.0B-4.3%	$6.2B
Retained Earnings	$2.0B+156.6%	$783.0M+373.8%	-$286.0M+55.5%	-$642.0M-129.3%	-$280.0M-123.2%	$1.2B+3.0%	$1.2B-78.5%	$5.4B+17.0%	$4.6B-6.5%	$5.0B-22.6%	$6.4B+16.3%	$5.5B+15.6%	$4.8B+18.2%	$4.0B-1.3%	$4.1B

Metric	Q4'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$56.7B-2.4%	$58.1B+5.2%	$55.2B+4.0%	$53.1B+6.5%	$49.9B+6.1%	$47.0B+9.2%	$43.1B-4.6%	$45.1B
Current Assets	$38.1B-3.0%	$39.2B+1.8%	$38.5B+5.9%	$36.4B+5.1%	$34.6B-3.2%	$35.8B+8.7%	$32.9B-5.7%	$34.9B
Cash & Equivalents	$3.9B+41.8%	$2.8B-39.5%	$4.6B+18.6%	$3.9B+16.5%	$3.3B-12.7%	$3.8B+32.9%	$2.9B-44.1%	$5.1B
Inventory	$18.0B-10.5%	$20.1B+14.6%	$17.6B+4.3%	$16.8B+4.2%	$16.2B-4.4%	$16.9B+8.2%	$15.6B+4.4%	$15.0B
Goodwill	$577.0M-95.0%	$11.6B+19.5%	$9.7B+0.2%	$9.7B+8.8%	$8.9B+62.3%	$5.5B+16.1%	$4.7B0.0%	$4.7B
Total Liabilities	$59.5B-2.4%	$61.0B+4.9%	$58.1B+3.9%	$55.9B+5.8%	$52.8B+5.7%	$50.0B+7.9%	$46.3B-4.1%	$48.3B
Current Liabilities	$42.0B-3.1%	$43.3B+7.6%	$40.3B+3.5%	$38.9B+6.1%	$36.7B+4.1%	$35.2B+1.6%	$34.7B-2.7%	$35.6B
Long-Term Debt	$8.2B-1.2%	$8.3B-7.0%	$9.0B+12.6%	$8.0B+11.8%	$7.1B+1.0%	$7.1B+67.2%	$4.2B-9.3%	$4.7B
Total Equity	-$2.8B+1.8%	-$2.9B-0.2%	-$2.9B-3.5%	-$2.8B+5.7%	-$2.9B+1.4%	-$3.0B+8.7%	-$3.3B-2.0%	-$3.2B
Retained Earnings	$1.7B+19.0%	$1.5B+30.4%	$1.1B+42.5%	$783.0M+17.9%	$664.0M+134.6%	$283.0M+1921.4%	$14.0M+104.9%	-$286.0M

Not reported in any period shown, so not listed: Accounts Receivable.

CAH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CAH quarterly cash flow statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Operating Cash Flow	$5.2B+115.9%	$2.4B-36.3%	$3.8B+32.3%	$2.8B-10.4%	$3.2B+30.7%	$2.4B+23.9%	$2.0B-28.0%	$2.7B-1.7%	$2.8B+133.8%	$1.2B-60.1%	$3.0B+17.0%	$2.5B+0.6%	$2.5B+46.1%	$1.7B+46.9%	$1.2B
Capital Expenditures	$649.0M+18.6%	$547.0M+7.0%	$511.0M+6.2%	$481.0M+24.3%	$387.0M-3.3%	$400.0M+6.7%	$375.0M+14.3%	$328.0M-14.6%	$384.0M-0.8%	$387.0M-16.8%	$465.0M+55.0%	$300.0M+20.5%	$249.0M+27.7%	$195.0M-25.0%	$260.0M
Free Cash Flow	$4.5B+144.6%	$1.9B-43.1%	$3.3B+37.6%	$2.4B-15.2%	$2.8B+37.4%	$2.0B+28.0%	$1.6B-33.8%	$2.4B+0.4%	$2.4B+199.1%	$797.0M-68.2%	$2.5B+11.9%	$2.2B-1.5%	$2.3B+48.5%	$1.5B+67.2%	$916.0M
Investing Cash Flow	-$2.6B+53.8%	-$5.6B-202.5%	-$1.8B-307.3%	-$454.0M-180.1%	$567.0M+250.0%	-$378.0M-176.7%	$493.0M+45.9%	$338.0M+106.0%	-$5.6B-1284.7%	-$405.0M+90.1%	-$4.1B-380.6%	-$849.0M+0.1%	-$850.0M+64.2%	-$2.4B-530.0%	-$377.0M
Financing Cash Flow	-$1.6B-182.6%	$1.9B+329.0%	-$847.0M+72.2%	-$3.1B-23.9%	-$2.5B-87.0%	-$1.3B+40.1%	-$2.2B+4.1%	-$2.3B-0.7%	-$2.3B-160.8%	$3.7B+428.9%	-$1.1B-1998.3%	$60.0M+108.5%	-$710.0M-358.2%	$275.0M+160.6%	-$454.0M
Dividends Paid	$491.0M-0.6%	$494.0M-1.0%	$499.0M-5.0%	$525.0M-6.1%	$559.0M-2.4%	$573.0M+0.7%	$569.0M-1.4%	$577.0M-0.7%	$581.0M+0.7%	$577.0M+12.7%	$512.0M+11.3%	$460.0M+10.8%	$415.0M+17.6%	$353.0M+17.7%	$300.0M
Share Buybacks	$1.4B+77.5%	$765.0M+2.0%	$750.0M-62.5%	$2.0B+100.0%	$1.0B+400.0%	$200.0M-42.9%	$350.0M-41.7%	$600.0M+9.1%	$550.0M-8.3%	$600.0M-7.8%	$651.0M-37.2%	$1.0B+53.9%	$673.0M+49.6%	$450.0M0.0%	$450.0M

Metric	Q4'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$1.8B+165.7%	$686.0M-29.5%	$973.0M-36.3%	$1.5B-47.6%	$2.9B+835.6%	-$396.0M+76.0%	-$1.6B-179.1%	$2.1B
Capital Expenditures	$146.0M+11.5%	$131.0M+21.3%	$108.0M-53.4%	$232.0M+84.1%	$126.0M+27.3%	$99.0M+10.0%	$90.0M-53.4%	$193.0M
Free Cash Flow	$1.7B+202.2%	$555.0M-35.8%	$865.0M-33.2%	$1.3B-53.5%	$2.8B+663.0%	-$495.0M+71.5%	-$1.7B-192.0%	$1.9B
Investing Cash Flow	-$181.0M+90.9%	-$2.0B-1294.4%	-$142.0M+91.3%	-$1.6B+43.7%	-$2.9B-196.9%	-$976.0M-1009.1%	-$88.0M-153.0%	$166.0M
Financing Cash Flow	-$483.0M+6.9%	-$519.0M-371.8%	-$110.0M-116.8%	$656.0M+230.4%	-$503.0M-121.6%	$2.3B+530.9%	-$540.0M+37.1%	-$859.0M
Dividends Paid	$114.0M-10.9%	$128.0M-0.8%	$129.0M+7.5%	$120.0M-3.2%	$124.0M-3.1%	$128.0M0.0%	$128.0M+4.9%	$122.0M
Share Buybacks	-$808.0M+111.0%	$383.0M+2.1%	$375.0M	$0-100.0%	$375.0M+2400.0%	$15.0M-96.0%	$375.0M	$0

CAH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CAH quarterly financial ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Gross Margin	3.8%+0.2pp	3.7%+0.4pp	3.3%-0.1pp	3.4%-0.2pp	3.6%-0.6pp	4.2%-0.3pp	4.5%-0.2pp	4.7%-0.5pp	5.3%+0.2pp	5.0%-0.4pp	5.4%-0.2pp	5.6%-0.1pp	5.7%+0.8pp	4.9%+0.6pp	4.2%
Operating Margin	1.0%0.0pp	1.0%+0.5pp	0.5%+0.2pp	0.4%+0.7pp	-0.3%-0.6pp	0.3%+3.0pp	-2.7%-4.1pp	1.4%+1.3pp	0.1%-1.5pp	1.6%-0.4pp	2.0%-0.1pp	2.1%0.0pp	2.1%+1.1pp	1.0%-0.7pp	1.7%
Net Margin	0.7%0.0pp	0.7%+0.3pp	0.4%+0.2pp	0.2%+0.7pp	-0.5%-0.9pp	0.4%+2.8pp	-2.4%-3.4pp	0.9%+0.8pp	0.2%-0.8pp	1.0%-0.2pp	1.2%0.0pp	1.2%-0.1pp	1.3%+1.0pp	0.3%-0.7pp	1.0%
Return on Equity	N/A	N/A	N/A	N/A	N/A	34.1%+240.7pp	-206.6%-228.1pp	21.5%+17.3pp	4.2%-14.7pp	18.9%-2.8pp	21.8%+2.3pp	19.4%+1.2pp	18.2%+12.6pp	5.6%-11.5pp	17.1%
Return on Assets	3.0%+0.1pp	2.9%+1.0pp	1.9%+1.1pp	0.8%+2.9pp	-2.1%-3.5pp	1.4%+10.4pp	-9.1%-12.4pp	3.3%+2.7pp	0.6%-2.6pp	3.2%-1.0pp	4.2%+0.1pp	4.0%-0.4pp	4.5%+3.2pp	1.3%-3.1pp	4.4%
Current Ratio	0.88-0.1x	0.940.0x	0.980.0x	1.00-0.1x	1.080.0x	1.120.0x	1.100.0x	1.070.0x	1.07-0.3x	1.34+0.2x	1.11-0.1x	1.26+0.1x	1.190.0x	1.220.0x	1.24
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	3.00-0.8x	3.78+2.6x	1.20-0.1x	1.320.0x	1.33+0.6x	0.76-0.1x	0.83+0.3x	0.50-0.1x	0.62+0.2x	0.39
FCF Margin	1.8%+0.9pp	0.8%-0.6pp	1.4%+0.3pp	1.1%-0.4pp	1.5%+0.3pp	1.3%+0.2pp	1.0%-0.6pp	1.6%-0.1pp	1.7%+1.1pp	0.6%-1.4pp	2.1%-0.1pp	2.2%-0.3pp	2.5%+1.0pp	1.5%+0.7pp	0.9%

Metric	Q4'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	4.1%+0.5pp	3.6%0.0pp	3.6%	N/A	N/A	3.5%-0.1pp	3.6%+0.5pp	3.1%
Operating Margin	0.8%-0.2pp	1.1%0.0pp	1.0%	N/A	N/A	1.0%-0.1pp	1.1%+0.4pp	0.7%
Net Margin	0.7%-0.1pp	0.7%0.0pp	0.7%	N/A	N/A	0.7%-0.1pp	0.8%+0.4pp	0.4%
Return on Assets	0.7%-0.1pp	0.8%0.0pp	0.8%	N/A	N/A	0.9%-0.1pp	1.0%+0.5pp	0.5%
Current Ratio	0.910.0x	0.91-0.1x	0.960.0x	0.940.0x	0.94-0.1x	1.02+0.1x	0.950.0x	0.98
FCF Margin	2.8%+1.9pp	0.9%-0.5pp	1.4%	N/A	N/A	-0.9%+2.4pp	-3.3%-6.5pp	3.2%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$2.9B), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.88), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Cencora Inc. COR

$61.5B

McKesson MCK

$104.2B

Henry Schein, Inc. HSIC

$10.0B

Resmed RMD

$34.7B

Alcon Inc ALC

$34.8B

Where Cardinal Health Inc Ranks

Frequently Asked Questions

What is Cardinal Health Inc's annual revenue?

Cardinal Health Inc (CAH) reported $254.2B in total revenue for fiscal year 2026. This represents a 14.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cardinal Health Inc's revenue growing?

Cardinal Health Inc (CAH) revenue grew by 14.2% year-over-year, from $222.6B to $254.2B in fiscal year 2026.

Is Cardinal Health Inc profitable?

Yes, Cardinal Health Inc (CAH) reported a net income of $1.7B in fiscal year 2026, with a net profit margin of 0.7%.

What is Cardinal Health Inc's EBITDA?

Cardinal Health Inc (CAH) had EBITDA of $3.6B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cardinal Health Inc have?

As of fiscal year 2026, Cardinal Health Inc (CAH) had $4.9B in cash and equivalents against $7.0B in long-term debt.

What is Cardinal Health Inc's gross margin?

Cardinal Health Inc (CAH) had a gross margin of 3.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cardinal Health Inc's operating margin?

Cardinal Health Inc (CAH) had an operating margin of 1.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Cardinal Health Inc's net profit margin?

Cardinal Health Inc (CAH) had a net profit margin of 0.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Cardinal Health Inc pay dividends?

Yes, Cardinal Health Inc (CAH) paid $2.04 per share in dividends during fiscal year 2026.

What is Cardinal Health Inc's free cash flow?

Cardinal Health Inc (CAH) generated $4.5B in free cash flow during fiscal year 2026. This represents a 144.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cardinal Health Inc's operating cash flow?

Cardinal Health Inc (CAH) generated $5.2B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Cardinal Health Inc's total assets?

Cardinal Health Inc (CAH) had $57.3B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Cardinal Health Inc's capital expenditures?

Cardinal Health Inc (CAH) invested $649.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Cardinal Health Inc buy back shares?

Yes, Cardinal Health Inc (CAH) spent $1.4B on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Cardinal Health Inc have outstanding?

Cardinal Health Inc (CAH) had 233M shares outstanding as of fiscal year 2026.

What is Cardinal Health Inc's current ratio?

Cardinal Health Inc (CAH) had a current ratio of 0.88 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

What is Cardinal Health Inc's return on assets (ROA)?

Cardinal Health Inc (CAH) had a return on assets of 3.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Why is Cardinal Health Inc's debt-to-equity ratio negative or not reported?

Cardinal Health Inc (CAH) has negative shareholder equity of -$2.9B as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Cardinal Health Inc's Altman Z-Score?

Cardinal Health Inc (CAH) has an Altman Z-Score of 5.07, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cardinal Health Inc's Piotroski F-Score?

Cardinal Health Inc (CAH) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cardinal Health Inc's earnings high quality?

Cardinal Health Inc (CAH) has an earnings quality ratio of 3.02x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cardinal Health Inc cover its interest payments?

Cardinal Health Inc (CAH) has an interest coverage ratio of 7.51x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cardinal Health Inc?

Cardinal Health Inc (CAH) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.